Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7759/cureus.12917 http://scihub22266oqcxt.onion/10.7759/cureus.12917 33654600!7906080!33654600     free     free     free       Cureus 2021 ; 13 (1): e12917 Nephropedia Template TP {{tp|p=33654600|t=2021. New-Onset Atrial Fibrillation and Multiple Systemic Emboli in a COVID-19 Patient |pdf=|usr=}}{{33654600}} gab.com Text New-Onset Atrial Fibrillation and Multiple Systemic Emboli in a COVID-19 Patient JO: Cureus http://www.kidney.de/pget.php?&tw=1&pmid=33654600 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was declared a pandemic by the World Health Organization in March 2020. Initially, infected patients presented with fever, nonproductive cough, dyspnea, myalgia, shortness of breath, and radiographic evidence of pneumonia. However, others presented with atypical cardiac manifestation. As this disease is new, the full picture of the disease presentation is not fully understood. Since December 2019, many morbidities related to coronavirus disease-2019 (COVID-19) were documented, including vascular complications like venous thromboembolism (VTE), pulmonary embolism (PE), and deep vein thrombosis (DVT) in acutely ill COVID-19 patients. Hereby, we are writing a case of a patient with COVID-19 infection suffering from new-onset atrial fibrillation (AF). It was complicated by multiple arterial embolisms involving different organs despite the use of an intermediate dose of low-molecular-weight heparin (LMWH), and the patient was eventually discharged home on a direct-acting oral anticoagulant (DOAC). Twit Text FOAVip New-Onset Atrial Fibrillation and Multiple Systemic Emboli in a COVID-19 Patient ????Cureus http://www.kidney.de/pget.php?&tw=1&pmid=33654600 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33654600 #FOAvip English Wikipedia <ref>{{Cite pmid|33654600}}</ref> New-Onset Atrial Fibrillation and Multiple Systemic Emboli in a COVID-19 Patient #MMPMID33654600 Al-Abbas O; Alshaikhli A; Amran HA Cureus 2021[Jan]; 13 (1): e12917 PMID33654600show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was declared a pandemic by the World Health Organization in March 2020. Initially, infected patients presented with fever, nonproductive cough, dyspnea, myalgia, shortness of breath, and radiographic evidence of pneumonia. However, others presented with atypical cardiac manifestation. As this disease is new, the full picture of the disease presentation is not fully understood. Since December 2019, many morbidities related to coronavirus disease-2019 (COVID-19) were documented, including vascular complications like venous thromboembolism (VTE), pulmonary embolism (PE), and deep vein thrombosis (DVT) in acutely ill COVID-19 patients. Hereby, we are writing a case of a patient with COVID-19 infection suffering from new-onset atrial fibrillation (AF). It was complicated by multiple arterial embolisms involving different organs despite the use of an intermediate dose of low-molecular-weight heparin (LMWH), and the patient was eventually discharged home on a direct-acting oral anticoagulant (DOAC). ?New-Onset Atrial Fibrillation and Multiple Systemic Emboli in a COVID-(epmc).pdf DeepDyve Pubget Overpricing